Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On
Review Article | By G Muntané-Carol, A Alperi, J Rodés-Cabau et al.
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Clinical Trial | By ACCORD Study Group, HC Gerstein, ME Miller et al.
Original Research | By J Schroder, MM Michelsen, ND Mygind et al.
Review Article | By M Biswas, SK Kali.
PURPOSE - It was aimed to determine the aggregated risk of MACE (major adverse cardiovascular events) in stable CAD patients carrying CYP2C19 LoF alleles taking clopidogrel. METHODS - Literature was searched in different databases for relevant studies. Aggregated risk was estimated using a fixed/random effect model where p-value<0.05 was considered statistically significant. RESULTS...
Clinical Trial | By H Kawashima , K Takahashi , the SYNTAX Extended Survival Investigators et al.
BACKGROUND - The long-term clinical benefit after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with total occlusions (TOs) and complex coronary artery disease has not yet been clarified. OBJECTIVES - The objective of this analysis was to assess 10-year all-cause mortality in patients with TOs undergoing PCI or CABG. M...
Original Research | By MQ Li, Y Wang, HW Fei et al.
During the routine follow-up of adult patients with pulmonary arterial hypertension associated with atrial septal defects (ASD-PAH), the suitability of shunt closure depends on the invasive right heart catheterization (RHC). It is difficult to grasp the timing of RHC shunt closure for moderate-severe PAH. This retrospective cross-sectional study was designed to investigate which echocardiographic variables are related to pulmonary ...
Original Research | By M Bossard, P Gao, W Boden et al.
OBJECTIVE - Approximately 10% of patients with myocardial infarction (MI) have no obstructive coronary artery disease. The prognosis and role of intensified antiplatelet therapy in those patients were evaluated. METHODS - We analysed data from the Clopidogrel and Aspirin Optimal Dose Usage to Reduce Recurrent Events–Seventh Organisation to Assess Strategies in Ischaemic Symptoms ...
Clinical Trial | By JAnn Lindenfeld; WT Abraham; PA Grayburn et al.
IMPORTANCE - Transcatheter mitral valve repair (TMVr) plus maximally tolerated guideline-directed medical therapy (GDMT) reduced heart failure (HF) hospitalizations (HFHs) and all-cause mortality (ACM) in symptomatic patients with HF and secondary mitral regurgitation (SMR) compared with GDMT alone in the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functi...
Clinical Trial | By XFGao, Z Ge, and for the ULTIMATE Investigators et al.